Perrigo (PRGO) Net Income (2012 - 2026)
Perrigo's (PRGO) quarterly Net Income came in at -$8.7 million in Q1 2026, down 33.85% year-on-year from -$13.2 million in Q1 2025, and down 148.57% on a QoQ basis from -$3.5 million in Q4 2025.
Perrigo (PRGO) Net Income (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Net Income data on file, last reported at -$8.7 million in Q1 2026.
- On a quarterly basis, Net Income fell 33.85% year-over-year to -$8.7 million in Q1 2026; TTM through Mar 2026 was -$25.3 million, a 62.18% decrease from a year earlier, with the FY2025 full-year figure at -$23.1 million, down 108.11% from the prior year.
- Net Income for Q1 2026 stood at -$8.7 million, down from -$3.5 million in the prior quarter.
- Over the last five years, Net Income for PRGO reached as high as $2.7 million in Q4 2022 and fell as low as -$11.0 million in Q4 2022.
- Historically, Net Income has averaged -$3.6 million across 5 years, with a median of -$3.0 million in 2024.
- Across the five-year window, Net Income surged 154.0% in 2022 and slumped 440.0% in 2024, its largest moves.
- Year by year, Net Income stood at -$11.0 million in 2022, then soared by 58.18% to -$4.6 million in 2023, then jumped by 34.78% to -$3.0 million in 2024, then decreased by 16.67% to -$3.5 million in 2025, then sank by 148.57% to -$8.7 million in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$8.7 million in Q1 2026, -$3.5 million in Q4 2025, and -$5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -8.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -8.70 Mn |
| Dec 31, 2025 | -3.50 Mn |
| Sep 27, 2025 | -5.20 Mn |
| Jun 28, 2025 | -7.90 Mn |
| Mar 29, 2025 | -6.50 Mn |
| Dec 31, 2024 | -3.00 Mn |
| Sep 28, 2024 | -3.40 Mn |
| Jun 29, 2024 | -2.70 Mn |
| Mar 30, 2024 | -2.10 Mn |
| Dec 31, 2023 | -4.60 Mn |
| Sep 30, 2023 | -1.20 Mn |
| Jul 1, 2023 | -500,000.00 |
| Apr 1, 2023 | -1.90 Mn |
| Dec 31, 2022 | -11.00 Mn |
| Oct 1, 2022 | 2.70 Mn |
| Jul 2, 2022 | -200,000.00 |
| Apr 2, 2022 | -1.10 Mn |
| Dec 31, 2021 | -22.50 Mn |
| Oct 2, 2021 | -5.00 Mn |
| Jul 3, 2021 | 54.20 Mn |